DIRE vs EWSfai
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
DIRE
This tool assists clinicians in evaluating the risk and potential success of prescribing opioids for chronic pain. It uses a scoring system based on seven factors to guide decision-making, but does not replace professional judgment.
- Opioid prescribing risk assessment
- Seven-factor scoring system
- Chronic non-malignant pain focus
- Decision-making aid for clinicians
- Risk vs. success prediction
Read full descriptionHide full description
The DIRE Score is a tool that can be used to aid clinicians in their decision-making process when considering prescribing opioids for chronic non-malignant pain. Using the DIRE Score, the clinician rates seven factors each on a scale of 1, 2 or 3 with 1 being the least favorable or highest risk for prescribing opioids and 3 being the most compelling or lowest risk for prescribing. The seven DIRE factors are: Diagnosis, Intractability, Risk (there are four risk factors—psychological and chemical health, patient reliability and social support/life roles) and Efficacy. Adding the scores for these seven factors gives a total of 7 – 21. A score of 7-13 was predictive of a low probability of success when prescribing opioids; whereas a score of 14-21 was more likely to be associated with a successful prescribing process and outcome. The DIRE Score does not take into account medical risk factors for opioid prescribing such as comorbid medical conditions (chronic obstructive lung disease, sleep apnea, concomitant use of benzodiazepines, etc.). The clinician should understand that active use of illicit drugs, drug diversion and other aberrant behaviors is incompatible with ongoing opioid prescribing no matter what the DIRE Score may be. The DIRE Score is not meant to be a substitute for sound clinical judgment in the context of any individual patient. This App is meant for informational use only, and is not intended to aid in the diagnosis, treatment or prevention of disease. Decisions about prescribing are solely the responsibility of the licensed prescriber.
EWSfai
Read full descriptionHide full description
EWSfai is a pioneering application designed to optimize patient care and clinical decision-making for both adults and children in emergency and ward settings. Developed by a team of specialists and proudly presented by Tizfai Technologies AB, this app integrates both Swedish and international guidelines to provide healthcare professionals with a comprehensive toolkit for assessments using various early warning score systems. Key Features: Integrated Guidelines: Incorporates the latest Swedish and international guidelines for early warning score assessments, ensuring adherence to best practices and standards of care. Interactive and Dynamic: User-friendly design enables seamless navigation, allowing healthcare providers quick access to critical features while maintaining depth of functionality. Evidence-Based: Built on Swedish and international evidence-based guidelines, providing reliable and accurate scoring. Benefits for Clinicians: Enhanced Decision-Making: Facilitates rapid and informed decisions at the point of care, contributing to improved patient outcomes and safety. Augmented Clinical Judgment: Acts as a supplementary resource that complements the clinician’s expertise and the unique clinical context of each patient encounter. What the App Does: EWSfai allows healthcare providers to easily store, edit, and share clinical data and measurements without the need for paper and pen. This app enables efficient transfer of data to colleagues, enhancing collaborative care without leaving the patient's side. It includes all major early warning scoring systems, making it a comprehensive tool for patient assessments. Disclaimers: Supportive Tool: EWSfai is intended as a supportive tool for healthcare professionals and is not meant to replace clinical judgment or diagnosis. Guideline-Based: The content is derived from Swedish and international guidelines but should be used in conjunction with individual patient assessment and clinical expertise. General Recommendations: While offering general recommendations, the app may not cover all aspects of patient management. Decisions should be tailored to each patient’s specific circumstances.
Screenshots
Verdict
The clearest difference is device support: DIRE at 3 against EWSfai's —. On price, in-app purchases and iOS requirement there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | DIRE | EWSfai |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) — better | — |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 1 — better | — |
| Update frequency | Every 51 months | — |
| Ads | No | — |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod — better | — |
| Requires iOS | 12.0 | 12.0 |
| Further details — not scored | ||
| Size | 8 MB | 27 MB |
| Age rating | 17+ | 17+ |
| Developer | Riemenrade Studios LLC | Kamal Ahmed |
In-app purchases
DIRE
No in-app purchases
EWSfai
No in-app purchases





